"I Can't Even Hold a Bowl Without Shaking — Am I Doomed to Live Like This Forever?" She Was 65. Twelve Years of Parkinson's. Her Family Had One Last Hope.
Aunt Chen was 53 when her right hand first began to tremble. She told herself it was fatigue. Then the tremor spread. Then the stiffness came. Then the medication stopped working the way it used to — and the side effects arrived in its place: uncontrollable twisting movements that made strangers stare and made her want to stop leaving the house.
By the time she was 65, Parkinson's disease had taken twelve years from her. She could no longer walk independently. She could not hold a spoon without dropping it. She could not button her own clothes. Every meal was a humiliation. Every morning was a negotiation with a body that no longer obeyed her.
One evening, she dropped her spoon again, looked at her trembling hands, and sobbed the question her family had been afraid to ask: "Am I doomed to live like this forever?"
Her family had already tried everything the local hospitals could offer. Medication adjustments. Physiotherapy. Specialist consultations that ended with the same answer: this is as good as it gets. Then someone mentioned Dr. Sun Bomin at Ruijin Hospital, Shanghai Jiao Tong University — and the words deep brain stimulation.
They made the journey to Shanghai.
Understanding Parkinson's Disease and Deep Brain Stimulation: Why Surgical Expertise Is Everything
Parkinson's disease is a progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra. As dopamine levels fall, the brain's motor control circuits become dysregulated — producing the tremor, rigidity, bradykinesia, and postural instability that define the disease. Deep brain stimulation (DBS) is the most effective surgical intervention for advanced Parkinson's — but its outcomes depend entirely on the precision of implantation and the expertise of the programming team:
- DBS does not cure Parkinson's — it modulates the circuit — DBS delivers continuous electrical stimulation to specific deep brain targets (most commonly the subthalamic nucleus or globus pallidus internus), interrupting the abnormal oscillatory activity that drives motor symptoms; it does not slow neurodegeneration but can dramatically reduce tremor, rigidity, and dyskinesia
- Target selection determines outcomes — the subthalamic nucleus (STN) is the most common DBS target for Parkinson's, offering broad motor benefit and potential medication reduction; the globus pallidus internus (GPi) is preferred in patients with prominent dyskinesia; incorrect target selection reduces efficacy and increases side effect risk
- Millimeter accuracy is non-negotiable — the STN measures approximately 5–8mm in its largest dimension; electrode placement must be accurate to within 1mm to achieve therapeutic stimulation without stimulating adjacent structures that cause speech, vision, or cognitive side effects
- Stereotactic frame-based and frameless navigation — high-precision stereotactic technology — using MRI-guided coordinates and intraoperative microelectrode recording — allows the surgeon to confirm electrode position in real time by listening to the characteristic firing patterns of target neurons before final implantation
- Microelectrode recording (MER) confirms target accuracy — intraoperative neurophysiological recording of individual neuron firing patterns allows the surgical team to map the target nucleus in real time and confirm that the electrode is in the optimal position before permanent implantation
- Awake surgery enables real-time feedback — DBS implantation is frequently performed with the patient awake during the targeting phase; this allows the team to test stimulation effects and confirm symptom improvement — and absence of side effects — before the electrode is fixed in place
- Post-operative programming is as important as surgery — DBS outcomes depend on expert post-operative programming of stimulation parameters (frequency, pulse width, amplitude, contact configuration); optimal programming requires a specialist movement disorder team with deep DBS programming experience and ongoing follow-up
- Patient selection is critical — DBS is most effective in patients with levodopa-responsive Parkinson's who have developed motor fluctuations or dyskinesia despite optimized medication; patients with significant cognitive impairment or atypical parkinsonism have poorer outcomes; careful pre-operative assessment is essential
About Dr. Sun Bomin 孙伯民
Dr. Sun Bomin is the Director of the Functional Neurosurgery Department at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine — China's leading center for deep brain stimulation and functional neurosurgery. He is internationally recognized as one of the world's foremost authorities on DBS for movement disorders, having performed thousands of DBS procedures over his career and conducted landmark research that has shaped clinical practice in China and beyond. His department is a national training center for DBS surgery and a reference site for DBS device manufacturers.
His clinical expertise spans:
- Deep brain stimulation for Parkinson's disease — STN-DBS and GPi-DBS for advanced Parkinson's with motor fluctuations, dyskinesia, and medication-refractory tremor; bilateral and unilateral implantation
- DBS for essential tremor and dystonia — thalamic DBS (Vim) for essential tremor; GPi-DBS for primary and secondary dystonia, including DYT1 and other genetic dystonias
- High-precision stereotactic implantation — MRI-guided stereotactic frame-based targeting with intraoperative microelectrode recording for millimeter-accurate electrode placement
- Post-operative DBS programming — expert optimization of stimulation parameters across all DBS platforms, including directional stimulation and adaptive DBS systems
- Functional neurosurgery for psychiatric disorders — DBS for treatment-refractory obsessive-compulsive disorder (OCD) and research protocols for other psychiatric indications
- Movement disorder research — landmark clinical research in DBS outcomes, biomarker-guided programming, and closed-loop adaptive stimulation systems
The Case That Proved Twelve Years of Parkinson's Was Not the End
The Situation
A 65-year-old woman. Twelve years of progressive Parkinson's disease. Severe tremor, rigidity, and bradykinesia. Medication-induced dyskinesia — uncontrollable twisting movements that had become as disabling as the disease itself. Loss of independent walking. Inability to perform basic daily tasks. A family that had been told by multiple specialists: this is as good as it gets. One question: is there anything left to try?
The Assessment
Dr. Sun conducted a comprehensive pre-operative evaluation — reviewing Aunt Chen's medication history, levodopa responsiveness, motor fluctuation pattern, cognitive status, and imaging. He confirmed she was an excellent DBS candidate: her symptoms were levodopa-responsive, her cognitive function was preserved, and her dyskinesia was medication-induced rather than disease-related. He explained the procedure, the expected outcomes, and the post-operative programming process to her family in full. For the first time in years, they heard a doctor describe what life after treatment might look like.
The Procedure
Dr. Sun implanted bilateral DBS electrodes into Aunt Chen's subthalamic nuclei using high-precision stereotactic technology — MRI-guided coordinate planning combined with intraoperative microelectrode recording to confirm target accuracy in real time. Each electrode was positioned to within millimeter precision. Intraoperative stimulation testing confirmed immediate tremor suppression and absence of side effects before the electrodes were fixed. The implantable pulse generator was placed subcutaneously in the chest wall and connected to the electrodes. The system was activated and programmed in the days following surgery.
The Recovery
Within days of activation and initial programming, the tremors faded. Aunt Chen stood up from her chair — steadily, without assistance — for the first time in years. She reached for a cup of tea. She held it. She did not spill it. She looked at her hands — still, controlled, hers again — and smiled through tears. "I feel reborn," she said.
In the weeks that followed, Dr. Sun's team fine-tuned her stimulation parameters through a series of programming sessions. Her dyskinesia resolved as her medication was reduced. She began walking independently. She returned to cooking. She held her grandchildren's hands without shaking.
Outcome Summary
- ✅ Bilateral STN-DBS successfully implanted — millimeter-accurate electrode placement confirmed by intraoperative microelectrode recording and stimulation testing
- ✅ Tremor dramatically reduced — resting tremor suppressed within days of system activation; Aunt Chen could hold objects without shaking for the first time in years
- ✅ Dyskinesia resolved — medication-induced uncontrollable movements eliminated as levodopa dose was reduced following DBS activation
- ✅ Independent mobility restored — Aunt Chen regained the ability to walk without assistance and perform basic daily tasks independently
- ✅ Expert post-operative programming — ongoing stimulation optimization by Dr. Sun's specialist team to maintain and improve motor outcomes over time
"She was 65. Twelve years of Parkinson's had taken everything from her. Dr. Sun Bomin implanted electrodes with millimeter precision — and within days, she held a cup of tea without spilling it for the first time in years."
Why Shanghai for Parkinson's DBS Surgery?
- National center of excellence — Ruijin Hospital's Functional Neurosurgery Department is China's leading DBS center, with one of the highest procedure volumes in Asia; the depth of experience at this level directly translates to better targeting accuracy and programming outcomes
- Intraoperative microelectrode recording as standard — real-time neurophysiological confirmation of electrode position during implantation is routine at Ruijin; this technology reduces misplacement risk and improves long-term outcomes compared to imaging-guided implantation alone
- Expert post-operative programming team — DBS outcomes depend as much on programming as on surgery; Dr. Sun's team includes dedicated movement disorder specialists with deep DBS programming expertise across all major device platforms
- Full movement disorder multidisciplinary team — neurology, neurosurgery, neuropsychology, physiotherapy, and speech therapy are integrated within the same institution; comprehensive pre-operative assessment and post-operative rehabilitation are coordinated from the outset
- Significant cost advantage — Parkinson's DBS surgery in Shanghai — including device, implantation, and post-operative programming — costs a fraction of equivalent care in the US, UK, or Australia, with outcomes that are comparable or superior to Western centers
How CMCS Supports International Patients Considering Parkinson's DBS Surgery
- 🏥 Specialist access — direct connection to Dr. Sun Bomin and Ruijin Hospital's Functional Neurosurgery Department, including pre-operative assessment coordination and second opinion review of existing imaging and medication history
- 📋 Medical records, MRI, and medication history translation & coordination
- 🗣️ On-site medical interpretation at every consultation, procedure, programming session, and follow-up
- ✈️ Travel & logistics coordination — visa, accommodation, airport transfers
- 📞 24/7 concierge support from first inquiry through every stage of treatment
- 🔄 Post-treatment follow-up — ongoing DBS programming session coordination and long-term movement disorder monitoring support
📢 Subscribe to China Medical Concierge – Shanghai (CMCS)
We offer trusted medical tourism and personalized medical concierge services, giving you and your loved ones a reliable pathway to premium healthcare in China.
💬 Got questions? Drop a comment or send a DM – we're always here to help!
📢 Have your own incredible medical story in China? Share it with us in the comments below!
#ChinaMedicalTour #AffordableHealthcare #MedicalTourismChina #BritishInChina #ChinaHealthcare #MedicalConcierge #medicaltourismchina
🤝 Connect With CMCS
Struggling with long medical waitlists? Facing barriers to overseas treatment? China Medical Concierge - Shanghai (CMCS) helps international patients access premium medical care in Shanghai's top public & private hospitals, with end-to-end personalized support.
Contact us for international patient support:
📧 contract@medicalsh.com | 🌐 medicalsh.com
0件のコメント